Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy

Morbidelli, Lucia

Elsevier Science & Technology

01/2022

294

Dura

Inglês

9780323901901

15 a 20 dias

770

Descrição não disponível.
1. General Introduction to the book2. Angiogenesis: definition and role, cellular and molecular mechanisms, redundancy of angiogenic modulators, receptors and converging signaling3. Anti-angiogenic drugs (monotherapies): General characteristics; molecular mechanisms; efficacy and side effects4. Anti-angiogenic drugs (combination therapies): molecular mechanisms; efficacy and side effects5. Clinical applications in various cancers; state of the art of the approved protocols, ongoing clinical trials, gaps6. Antiangiogenic drugs as chemosensitizer in colorectal cancer7. Antiangiogenic drugs as chemosensitizer in lung cancer8. Antiangiogenic drugs as chemosensitizer for upper GI cancer9. Antiangiogenic drugs as chemosensitizer in breast cancer10. Antiangiogenic drugs as chemosensitizer in renal and genitourinary cancer11. Antiangiogenic drugs as chemosensitizer in skin cancer12. Antiangiogenic drugs as chemosensitizer in brain tumors13. Antiangiogenic drugs as chemosensitizer in circulating tumors14. Antiangiogenic drugs and radiosensitization: state of the art on protocols and experimental studies15. Resistance to combination treatments: mechanisms of resistance to antiangiogenic drugs and cross-talk with tumor cell mechanisms of resistance16. Combination of antiangiogenic drugs with immunotherapies: efficacious synergism; side effects and limits17. Prognostic and diagnostic biomarkers for therapy choice and to monitor antiangiogenic drug efficacy and toxicities18. Antiangiogenic strategies: one target or multitarget inhibitors; synthetic compounds, gene therapy and natural products19. Synthesis and application of dual inhibitors: rationale for development and state of the art of the studies20. Metronomic therapy: mechanisms, advantages and approved protocols alone or in combination21. Personalized medicine with tumor angiogenesis as diagnostic marker and therapeutic target22. General Conclusions and future perspectives
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
angiogenesis; chemotherapy; sensitizer; cancer; colorectal; lung; breast; renal; genitourinary; skin; brain; circulating tumor